Innov Clin Neurosci. 2025;22(1–3):11–13. Dear Editor: Thank you for your interest in this case report1 and for your insightful comments. I appreciate the thoroughness of your feedback and concur with
Innov Clin Neurosci. 2025;22(1–3):11–13. Dear Editor: Emerging data on sex differences in the efficacy and tolerability of antipsychotics in patients with schizophrenia are not taken into account in current guidelines,
by Eirini Beneki, MSc, MD, PhD(c); Kyriakos Dimitriadis, MD, PhD; Elias Zintzaras, MD, PhD; Panagiotis Kostakis, MD, PhD(c); Constantina Aggeli, MD, PhD; and Konstantinos Tsioufis, MD, PhD Drs. Beneki, Dimitriadis,
by Terry Correll, DO; Julie Gentile, MD, MBA; and Andrew B. Correll, MD Dr. T. Correll is Clinical Professor, Department of Psychiatry, Wright State University Boonshoft School of Medicine in
by Ragaviveka Gopalan, BSc, MS; Himanshi Pande, BA; Saralya Narayanan, BSc; and Adith Chinnaswami, MS, MBBS Ms. Gopalan and Dr. Chinnaswami are with MediSim VR in Chennai, India. Ms. Pande
by Mohammad Ibrahim, MBBS; Hassam Nasir Khan Alizai, MBBS; Izma Shahid, MBBS; and Muhammad Hannan Malik, MBBS, MCPS All authors are with Shaikh Zayed Hospital, Lahore in Lahore, Punjab, Pakistan.
